{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:20:08Z","timestamp":1791141608437,"version":"4.1.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2012,1,12]],"date-time":"2012-01-12T00:00:00Z","timestamp":1326326400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1002333","type":"journal-article","created":{"date-parts":[[2012,1,12]],"date-time":"2012-01-12T16:48:31Z","timestamp":1326386911000},"page":"e1002333","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":53,"title":["Global Analysis of Small Molecule Binding to Related Protein Targets"],"prefix":"10.1371","volume":"8","author":[{"given":"Felix A.","family":"Kruger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Overington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,1,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1136\/bmj.281.6252.1397","article-title":"Clinical pharmacology. Drug development.","volume":"281","author":"CF George","year":"1980","journal-title":"Br Med J"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1073\/pnas.0910200107","article-title":"Systematic discovery of nonobvious human disease models through orthologous phenotypes.","volume":"107","author":"KL McGary","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1073\/pnas.78.9.5773","article-title":"Possibility of extensive neutral evolution under stabilizing selection with special reference to nonrandom usage of synonymous codons.","volume":"78","author":"M Kimura","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd892","article-title":"The druggable genome.","volume":"1","author":"AL Hopkins","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nrd2199","article-title":"How many drug targets are there?","volume":"5","author":"JP Overington","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1367-5931(00)00229-5","article-title":"Chemogenomic approaches to drug discovery.","volume":"5","author":"PR Caron","year":"2001","journal-title":"Curr Opin Chem Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/prot.20768","article-title":"A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors.","volume":"62","author":"JS Surgand","year":"2006","journal-title":"Proteins"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1021\/jm900319e","article-title":"Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design.","volume":"52","author":"DE Gloriam","year":"2009","journal-title":"J Med Chem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/1471-2105-11-316","article-title":"A novel chemogenomics analysis of G protein-coupled receptors (GPCRs) and their ligands: a potential strategy for receptor de-orphanization.","volume":"11","author":"E van der Horst","year":"2010","journal-title":"BMC Bioinf"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nbt1068","article-title":"A small moleculekinase interaction map for clinical kinase inhibitors.","volume":"23","author":"MA Fabian","year":"2005","journal-title":"Nat Biotechnol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nbt1358","article-title":"A quantitative analysis of kinase inhibitor selectivity.","volume":"26","author":"MW Karaman","year":"2008","journal-title":"Nat Biotechnol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nchembio.530","article-title":"Navigating the kinome.","volume":"7","author":"JT Metz","year":"2011","journal-title":"Nat Chem Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/pro.355","article-title":"An enriched structural kinase database to enable kinome-wide structure-based analyses and drug discovery.","volume":"19","author":"N Brooijmans","year":"2010","journal-title":"Protein Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"13682","DOI":"10.1073\/pnas.0603236103","article-title":"Structural basis for ligand promiscuity in cytochrome P450 3A4.","volume":"103","author":"M Ekroos","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1747-0285.2009.00832.x","article-title":"On the origins of enzyme inhibitor selectivity and promiscuity: a case study of protein kinase binding to staurosporine.","volume":"74","author":"D Tanramluk","year":"2009","journal-title":"Chem Biol Drug Des"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10822-009-9260-9","article-title":"ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI). Interview by Wendy A. Warr.","volume":"23","author":"J Overington","year":"2009","journal-title":"J Comput Aided Mol Des"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1021\/ci050378m","article-title":"Bringing Chemical Data onto the Semantic Web.","volume":"46","author":"KR Taylor","year":"2006","journal-title":"J Chem Inf Mod"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1142\/S0218215793000071","article-title":"Retrieving and integrating data from multiple information sources.","volume":"2","author":"Y Arens","year":"1993","journal-title":"Int J Intell Coop I"},{"key":"ref19","first-page":"9","article-title":"Data integration: the teenage years.","author":"A Halevy","year":"2006"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/jbin.2001.1024","article-title":"Heterogeneous Database Integration in Biomedicine.","volume":"34","author":"W Sujansky","year":"2001","journal-title":"J Biomed Inf"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.drudis.2008.03.021","article-title":"Use of genetically modified rat models for translational medicine.","volume":"13","author":"J Cozzi","year":"2008","journal-title":"Drug Discov Today"},{"key":"ref22","article-title":"ChEMBL 10.","author":"LJ Bellis","year":"2011"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrd3367","article-title":"Probing the links between in vitro potency, ADMET and physicochemical parameters.","volume":"10","author":"MP Gleeson","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"ref24","first-page":"331","article-title":"Tests for the uniform distribution.","author":"MS Stephens","year":"1986"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bmcl.2007.10.067","article-title":"In vitro SAR of pyrrolidine-containing histamine H3 receptor antagonists: trends across multiple chemical series.","volume":"18","author":"DL Nersesian","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.bmcl.2006.11.073","article-title":"4-[6-(2- Aminoethyl)naphthalen-2-yl]benzonitriles are potent histamine H3 receptor antagonists with high CNS penetration.","volume":"17","author":"LA Black","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/jpet.104.078303","article-title":"Pharmacological Properties of ABT-239 [4-(2- -benzofuran-5- yl)benzonitrile]: I. Potent and Selective Histamine H3 Receptor Antagonist with Drug-Like Properties.","volume":"313","author":"TA Esbenshade","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-2999(01)01518-7","article-title":"Species-related pharmacological heterogeneity of histamine H(3) receptors.","volume":"433","author":"L Ireland-Denny","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/sj.bjp.0703712","article-title":"Distinct pharmacology of rat and human histamine H(3) receptors: role of two amino acids in the third transmembrane domain.","volume":"131","author":"X Ligneau","year":"2000","journal-title":"Br J Pharmacol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0022-3565(24)39297-3","article-title":"Cloning of rat histamine H(3) receptor reveals distinct species pharmacological profiles.","volume":"293","author":"TW Lovenberg","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.genet.39.073003.114725","article-title":"Orthologs, paralogs, and evolutionary genomics.","volume":"39","author":"E Koonin","year":"2005","journal-title":"Annu Rev Genet"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1101\/gr.073585.107","article-title":"EnsemblCompara GeneTrees: Complete, duplication-aware phylogenetic trees in vertebrates.","volume":"19","author":"AJ Vilella","year":"2008","journal-title":"Genome Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2307\/2412448","article-title":"Distinguishing Homologous from Analogous Proteins.","volume":"19","author":"WM Fitch","year":"1970","journal-title":"Syst Zool"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1126\/science.278.5338.631","article-title":"A Genomic Perspective on Protein Families.","volume":"278","author":"RL Tatusov","year":"1997","journal-title":"Science"},{"key":"ref35","article-title":"An R Companion to Applied Regression. 2<sup>nd<\/sup> edition","author":"J Fox","year":"2011"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.2315699","article-title":"Deciphering the message in protein sequences: tolerance to amino acid substitutions.","volume":"247","author":"JU Bowie","year":"1990","journal-title":"Science"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1359-6446(05)03477-X","article-title":"Kinomics: characterizing the therapeutically validated kinase space.","volume":"10","author":"M Vieth","year":"2005","journal-title":"Drug Discov Today"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1021\/jm070543k","article-title":"Overcoming Undesirable hERG Potency of Chemokine Receptor Antagonists Using Baseline Lipophilicity Relationships.","volume":"51","author":"I Shamovsky","year":"2008","journal-title":"J Med Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/(SICI)1521-3773(19990315)38:6<736::AID-ANIE736>3.0.CO;2-R","article-title":"Hydrogen bonding, hydrophobic interactions, and failure of the rigid receptor hypothesis.","volume":"38","author":"AM Davis","year":"1999","journal-title":"Angewandt Chem Internatl Ed"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0960-894X(99)00119-5","article-title":"Switching androgen receptor antagonists to agonists by modifying C-ring substituents on piperidino-3,2-quinolinone.","volume":"9","author":"L Zhi","year":"1999","journal-title":"Bioorg Med Chem Lett"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1359-6446(04)03069-7","article-title":"Ligand efficiency: a useful metric for lead selection.","volume":"9","author":"A Hopkins","year":"2004","journal-title":"Drug Discov Today"},{"key":"ref42","first-page":"856","article-title":"Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery.","volume":"41","author":"MM Hann","year":"2001","journal-title":"J Chem Inf Mod"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/pro.143","article-title":"Evolutionary constraints on structural similarity in orthologs and paralogs.","volume":"18","author":"ME Peterson","year":"2009","journal-title":"Protein Sci"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2174\/156802611796391230","article-title":"Approaches for Receptor Deorphanization and Extensions of the Chemogenomics Concept to Phenotypic Space.","volume":"11","author":"E van der Horst","year":"2011","journal-title":"Cur Top Med Chem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"e16811","DOI":"10.1371\/journal.pone.0016811","article-title":"Chemogenomic Analysis of G-Protein Coupled Receptors and Their Ligands Deciphers Locks and Keys Governing Diverse Aspects of Signalling.","volume":"6","author":"JD Wichard","year":"2011","journal-title":"PloS One"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"D211","DOI":"10.1093\/nar\/gkp985","article-title":"The Pfam protein families database.","volume":"38","author":"RD Finn","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"ref47","article-title":"Pfam version 24.","author":"A Bateman","year":"2011"},{"key":"ref48","article-title":"Kinase SARfari.","author":"M Davies","year":"2011"},{"key":"ref49","article-title":"R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria.","year":"2011"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1021\/ci0496797","article-title":"LINGO, an Efficient Holographic Text Based Method To Calculate Biophysical Properties and Intermolecular Similarities.","volume":"45","author":"D Vidal","year":"2005","journal-title":"J Chem Inf Mod"},{"key":"ref51","article-title":"OEChem: version 1.7.4.","year":"2010"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002333","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T15:21:15Z","timestamp":1742311275000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002333"}},"subtitle":[],"editor":[{"given":"Greg","family":"Tucker-Kellogg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,1,12]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1002333","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717347853.792852804","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,12]]}}}